{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:13:40Z","timestamp":1786115620424,"version":"build-2736575974"},"reference-count":168,"publisher":"Bentham Science Publishers Ltd.","issue":"11","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Lipid-based nanocarriers, such as liposomes, niosomes, ethosomes, transferosomes,\nsolid lipid nanoparticles, nanostructured lipid carriers and nanoemulsions, have gained significant\ninterest in targeted drug delivery. In brain-targeted delivery, these nanosystems can be beneficial if\ngiven by the intranasal route. They can overcome the issue of poor drug distribution to the brain by\nconventional systems. Colloidal vesicles permeate the nasal mucosa due to their small size and\nresemblance to the structure of the cell membrane. Other lipid carriers permeate through the nasal\nmucosa due to their nanosize and higher partition to cellular lipids. Several studies have established\nthe intranasal nanocarrier-based drug delivery, the improved drug distribution to the brain and enhanced\ncognitive function in animal models. All lipid-based nanocarriers have shown such significant\nimprovement in in vitro or in vivo studies. However, there is a gap between the lab-scale development\nand its industrial application. This review will highlight the outcome of reported studies\non brain targeting by intranasal lipid-based nanosystems. It will help future researchers to identify\nthe potential of individual systems and focus on the \u2018gaps\u2019 for their successful clinical translation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115680266379726251115040906","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T05:24:12Z","timestamp":1782105852000},"page":"1135-1160","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipid-Based Nanocarriers for Intranasal Delivery: Revolutionizing Neurological Disorder Therapies"],"prefix":"10.2174","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1792-0652","authenticated-orcid":true,"given":"Nagapurkar","family":"Swati","sequence":"first","affiliation":[{"name":"Gitam School of Pharmacy, GITAM University, Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bappaditya","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Gitam School of Pharmacy, GITAM University, Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-30930-5_1","author":"Rai M.","year":"2019","unstructured":"Rai M.; Neurodegenerative diseases: The real problem and nanobiotechnological solutions. Nanobiotechnology in neurodegenerative diseases  2019,1-17","journal-title":"Nanobiotechnology in neurodegenerative diseases"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"105448","DOI":"10.1016\/j.jddst.2024.105448","volume":"93","author":"Revdekar A.","year":"2024","unstructured":"Revdekar A.; Shende P.; Intranasal administration of silibinin-loaded pullulan acetate nanocarriers: A pH-responsive approach for brain targeting in Alzheimer\u2019s disease. J Drug Deliv Sci Technol  2024,93,105448","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"103932","DOI":"10.1016\/j.jddst.2022.103932","volume":"78","author":"Bahadur S.","year":"2022","unstructured":"Bahadur S.; Jha M.K.; Emerging nanoformulations for drug targeting to brain through intranasal delivery: A comprehensive review. J Drug Deliv Sci Technol  2022,78,103932","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ijpharm.2019.05.032","volume":"565","author":"Chatterjee B.","year":"2019","unstructured":"Chatterjee B.; Gorain B.; Mohananaidu K.; Sengupta P.; Mandal U.K.; Choudhury H.; Targeted drug delivery to the brain via intranasal nanoemulsion: Available proof of concept and existing challenges. Int J Pharm  2019,565,258-268","journal-title":"Int J Pharm"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"114485","DOI":"10.1016\/j.addr.2022.114485","volume":"189","author":"Correia A.C.","year":"2022","unstructured":"Correia A.C.; Monteiro A.R.; Silva R.; Moreira J.N.; Sousa Lobo J.M.; Silva A.C.; Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood\u2013brain barrier (BBB) to manage neurological disorders. Adv Drug Deliv Rev  2022,189,114485","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.apsb.2021.02.012","volume":"11","author":"Costa C.P.","year":"2021","unstructured":"Costa C.P.; Moreira J.N.; Sousa Lobo J.M.; Silva A.C.; Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies. Acta Pharm Sin B  2021,11(4),925-940","journal-title":"Acta Pharm Sin B"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijbiomac.2017.12.056","volume":"109","author":"Raj R.","year":"2018","unstructured":"Raj R.; Wairkar S.; Sridhar V.; Gaud R.; Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity. Int J Biol Macromol  2018,109,27-35","journal-title":"Int J Biol Macromol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.yexcr.2017.03.061","volume":"358","author":"Campbell H.K.","year":"2017","unstructured":"Campbell H.K.; Maiers J.L.; DeMali K.A.; Interplay between tight junctions and adherens junctions. Exp Cell Res  2017,358(1),39-44","journal-title":"Exp Cell Res"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","volume":"165-166","author":"Pandit R.","year":"2020","unstructured":"Pandit R.; Chen L.; G\u00f6tz J.; The blood-brain barrier: Physiology and strategies for drug delivery. Adv Drug Deliv Rev  2020,165-166,1-14","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/pharmaceutics15010207","volume":"15","author":"Duong V.A.","year":"2023","unstructured":"Duong V.A.; Nguyen T.T.L.; Maeng H.J.; Recent advances in intranasal liposomes for drug, gene, and vaccine delivery. Pharmaceutics  2023,15(1),207","journal-title":"Pharmaceutics"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"121068","DOI":"10.1016\/j.ijpharm.2021.121068","volume":"608","author":"Dholakia J.","year":"2021","unstructured":"Dholakia J.; Prabhakar B.; Shende P.; Strategies for the delivery of antidiabetic drugs via intranasal route. Int J Pharm  2021,608,121068","journal-title":"Int J Pharm"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/17425247.2016.1206074","volume":"14","author":"Thwala L.N.","year":"2017","unstructured":"Thwala L.N.; Pr\u00e9at V.; Csaba N.S.; Emerging delivery platforms for mucosal administration of biopharmaceuticals: A critical update on nasal, pulmonary and oral routes. Expert Opin Drug Deliv  2017,14(1),23-36","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"155484","DOI":"10.1016\/j.phymed.2024.155484","volume":"127","author":"Tran K.N.","year":"2024","unstructured":"Tran K.N.; Kwon J.H.; Kim M.K.; Nguyen N.P.K.; Yang I.J.; Intranasal delivery of herbal medicine for disease treatment: A systematic review. Phytomedicine  2024,127,155484","journal-title":"Phytomedicine"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jconrel.2021.08.030","volume":"338","author":"Wang W.","year":"2021","unstructured":"Wang W.; Ye Z.; Gao H.; Ouyang D.; Computational pharmaceutics - A new paradigm of drug delivery. J Control Release  2021,338,119-136","journal-title":"J Control Release"},{"key":"ref=15","doi-asserted-by":"publisher","DOI":"10.1234\/ijpir.2023.10","volume":"2023","author":"Swati N.","year":"2023","unstructured":"Swati N.; Applications of nanotechnology in pharmacy. Intercont J Pharma Investigat Res  2023,2023(10)","journal-title":"Intercont J Pharma Investigat Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"10938","DOI":"10.1021\/acs.chemrev.5b00046","volume":"115","author":"Pattni B.S.","year":"2015","unstructured":"Pattni B.S.; Chupin V.V.; Torchilin V.P.; New developments in liposomal drug delivery. Chem Rev  2015,115(19),10938-10966","journal-title":"Chem Rev"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.colsurfa.2009.11.006","volume":"353","author":"Liu C.H.","year":"2010","unstructured":"Liu C.H.; Wu C.T.; Optimization of nanostructured lipid carriers for lutein delivery. Colloids Surf A Physicochem Eng Asp  2010,353(2-3),149-156","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"105585","DOI":"10.1016\/j.jddst.2024.105585","volume":"95","author":"Mirza R.","year":"2024","unstructured":"Mirza R.; Khan A.U.; Shah K.U.; Ullah N.; Nawaz A.; Ghani S.F.; Javed A.; Shah S.U.; Alasmari A.F.; Alharbi M.; Alasmari F.; Hafeez Z.; Brain targeting of cefepime loaded transfersomes based thermosensitive in situ gel via intranasal delivery: In vitro and in vivo studies. J Drug Deliv Sci Technol  2024,95,105585","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"114542","DOI":"10.1016\/j.biopha.2023.114542","volume":"162","author":"Yu S.","year":"2023","unstructured":"Yu S.; Li D.; Shi A.; Long Y.; Deng J.; Ma Y.; Li X.; Wen J.; Hu Y.; He X.; Wu Y.; Li N.; Zhao M.; Multidrug-loaded liposomes prevent ischemic stroke through intranasal administration. Biomed Pharmacother  2023,162,114542","journal-title":"Biomed Pharmacother"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1021\/acs.molpharmaceut.4c00387","volume":"21","author":"Miao K.","year":"2024","unstructured":"Miao K.; Xia X.; Zou Y.; Shi B.; Small scale, big impact: Nanotechnology-enhanced drug delivery for brain diseases. Mol Pharm  2024,21(8),3777-3799","journal-title":"Mol Pharm"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"105855","DOI":"10.1016\/j.jddst.2024.105855","volume":"98","author":"Sonwani A.","year":"2024","unstructured":"Sonwani A.; Pathak A.; Jain K.; Nanocarriers-mediated nose-to-brain drug delivery: A novel approach for the management of Alzheimer\u2019s disease. J Drug Deliv Sci Technol  2024,98,105855","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"134962","DOI":"10.1016\/j.ijbiomac.2024.134962","volume":"278","author":"Khodaverdi K.","year":"2024","unstructured":"Khodaverdi K.; Bakhshi A.; Mozafari M.R.; Naghib S.M.; A review of chitosan-based nanocarriers as drug delivery systems for brain diseases: Critical challenges, outlooks and promises. Int J Biol Macromol  2024,278(Pt 3),134962","journal-title":"Int J Biol Macromol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"104726","DOI":"10.1016\/j.jddst.2023.104726","volume":"86","author":"Rai G.","year":"2023","unstructured":"Rai G.; Gauba P.; Dang S.; Recent advances in nanotechnology for Intra-nasal drug delivery and clinical applications. J Drug Deliv Sci Technol  2023,86,104726","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/pharmaceutics10030116","volume":"10","author":"G\u00e4nger S.","year":"2018","unstructured":"G\u00e4nger S.; Schindowski K.; Tailoring formulations for intranasal nose-to-brain delivery: A review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa. Pharmaceutics  2018,10(3),116","journal-title":"Pharmaceutics"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s40005-022-00589-5","volume":"53","author":"Jeong S.H.","year":"2023","unstructured":"Jeong S.H.; Jang J.H.; Lee Y.B.; Drug delivery to the brain via the nasal route of administration: Exploration of key targets and major consideration factors. J Pharm Investig  2023,53(1),119-152","journal-title":"J Pharm Investig"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"a028241","DOI":"10.1101\/cshperspect.a028241","volume":"9","author":"Bustamante-Marin X.M.","year":"2017","unstructured":"Bustamante-Marin X.M.; Ostrowski L.E.; Cilia and mucociliary clearance. Cold Spring Harb Perspect Biol  2017,9(4),a028241","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1208\/s12249-022-02439-x","volume":"23","author":"Mohananaidu K.","year":"2022","unstructured":"Mohananaidu K.; Chatterjee B.; Mohamed F.; Mahmood S.; Hamed Almurisi S.; Thermoreversible carbamazepine in situ gel for intranasal delivery: Development and in vitro, ex vivo evaluation. AAPS PharmSciTech  2022,23(8),288","journal-title":"AAPS PharmSciTech"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s40005-020-00482-z","volume":"50","author":"Gao M.","year":"2020","unstructured":"Gao M.; Shen X.; Mao S.; Factors influencing drug deposition in the nasal cavity upon delivery via nasal sprays. J Pharm Investig  2020,50(3),251-259","journal-title":"J Pharm Investig"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jconrel.2023.04.021","volume":"358","author":"Saha P.","year":"2023","unstructured":"Saha P.; Kathuria H.; Pandey M.M.; Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson\u2019s disease. J Control Release  2023,358,293-318","journal-title":"J Control Release"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"103656","DOI":"10.1016\/j.jddst.2022.103656","volume":"75","author":"Sastri K.T.","year":"2022","unstructured":"Sastri K.T.; Gupta N.V.; M S.; Chakraborty S.; Kumar H.; Chand P.; Balamuralidhara V.; Gowda D.V.; Nanocarrier facilitated drug delivery to the brain through intranasal route: A promising approach to transcend bio-obstacles and alleviate neurodegenerative conditions. J Drug Deliv Sci Technol  2022,75,103656","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s13346-020-00891-5","volume":"12","author":"Keller L.A.","year":"2022","unstructured":"Keller L.A.; Merkel O.; Popp A.; Intranasal drug delivery: Opportunities and toxicologic challenges during drug development. Drug Deliv Transl Res  2022,12(4),735-757","journal-title":"Drug Deliv Transl Res"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"121180","DOI":"10.1016\/j.ijpharm.2021.121180","volume":"609","author":"Xu H.","year":"2021","unstructured":"Xu H.; Cai L.; Hufnagel S.; Cui Z.; Intranasal vaccine: Factors to consider in research and development. Int J Pharm  2021,609,121180","journal-title":"Int J Pharm"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.jamda.2023.04.015","volume":"24","author":"Ramsay R.E.","year":"2023","unstructured":"Ramsay R.E.; Becker D.A.; Vazquez B.; Birnbaum A.K.; Misra S.N.; Carrazana E.; Rabinowicz A.L.; Acute abortive therapies for seizure clusters in long-term care. J Am Med Dir Assoc  2023,24(8),1225-1232","journal-title":"J Am Med Dir Assoc"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"101631","DOI":"10.1016\/j.apmt.2022.101631","volume":"29","author":"Formica M.L.","year":"2022","unstructured":"Formica M.L.; Real D.A.; Picchio M.L.; Catlin E.; Donnelly R.F.; Paredes A.J.; On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles. Appl Mater Today  2022,29,101631","journal-title":"Appl Mater Today"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"105658","DOI":"10.1016\/j.jddst.2024.105658","volume":"96","author":"Ansari M.S.","year":"2024","unstructured":"Ansari M.S.; Ali A.; Rashid M.A.; Alhamhoom Y.; Sultana N.; Waheed A.; Alam M.S.; Aqil M.; Sultana Y.; BBD assisted in-situ nanoliposomes of esculin hydrate via intranasal delivery for the amelioration of Parkinson\u2019s disease. J Drug Deliv Sci Technol  2024,96,105658","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejpb.2023.06.007","volume":"190","author":"Subhash Hinge N.","year":"2023","unstructured":"Subhash Hinge N.; Kathuria H.; Monohar Pandey M.; Rivastigmine-DHA ion-pair complex improved loading in hybrid nanoparticles for better amyloid inhibition and nose-to-brain targeting in Alzheimer\u2019s. Eur J Pharm Biopharm  2023,190,131-149","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.nut.2009.08.001","volume":"26","author":"Henkin R.I.","year":"2010","unstructured":"Henkin R.I.; Inhaled insulin\u2014Intrapulmonary, intranasal, and other routes of administration: Mechanisms of action. Nutrition  2010,26(1),33-39","journal-title":"Nutrition"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"112905","DOI":"10.1016\/j.ejmech.2020.112905","volume":"209","author":"Mignani S.","year":"2021","unstructured":"Mignani S.; Shi X.; Karpus A.; Majoral J.P.; Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugs. Eur J Med Chem  2021,209,112905","journal-title":"Eur J Med Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3390\/pharmaceutics14051073","volume":"14","author":"Tai J.","year":"2022","unstructured":"Tai J.; Han M.; Lee D.; Park I.H.; Lee S.H.; Kim T.H.; Different methods and formulations of drugs and vaccines for nasal administration. Pharmaceutics  2022,14(5),1073","journal-title":"Pharmaceutics"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.22270\/jddt.v10i2-s.4029","volume":"10","author":"Sabale A.S.","year":"2020","unstructured":"Sabale A.S.; Kulkarni A.D.; Sabale A.S.; Nasal in situ gel: Novel approach for nasal drug delivery. J Drug Deliv Ther  2020,10(2-s),183-197","journal-title":"J Drug Deliv Ther"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"119832","DOI":"10.1016\/j.ijpharm.2020.119832","volume":"589","author":"Fonseca-Santos B.","year":"2020","unstructured":"Fonseca-Santos B.; Chorilli M.; The uses of resveratrol for neurological diseases treatment and insights for nanotechnology based-drug delivery systems. Int J Pharm  2020,589,119832","journal-title":"Int J Pharm"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.2174\/0113816128299356240626114734","volume":"30","author":"Joshi P.","year":"2024","unstructured":"Joshi P.; Rao G.S.N.K.; Chatterjee B.; Scope and application of hot melt extrusion in the development of controlled and sustained release drug delivery systems. Curr Pharm Des  2024,30(32),2513-2523","journal-title":"Curr Pharm Des"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jddst.2017.09.022","volume":"43","author":"Md S.","year":"2018","unstructured":"Md S.; Bhattmisra S.K.; Zeeshan F.; Shahzad N.; Mujtaba M.A.; Srikanth Meka V.; Radhakrishnan A.; Kesharwani P.; Baboota S.; Ali J.; Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders. J Drug Deliv Sci Technol  2018,43,295-310","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4103\/jrptps.JRPTPS_59_19","volume":"9","author":"Kumar R.","year":"2020","unstructured":"Kumar R.; Thakur A.; Singh P.K.; Biswal S.S.; Kumar N.; Jha C.B.; Singh G.; Kaur C.; Wadhwa S.; Drug delivery through nose: A noninvasive technique for brain targeting. J Rep Pharma Sci  2020,9(1),168","journal-title":"J Rep Pharma Sci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3390\/pharmaceutics16060703","volume":"16","author":"Sipos B.","year":"2024","unstructured":"Sipos B.; Katona G.; Cs\u00f3ka I.; Risperidone-loaded nasal thermosensitive polymeric micelles: Quality by design-based formulation study. Pharmaceutics  2024,16(6),703","journal-title":"Pharmaceutics"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"3692065","DOI":"10.1155\/2022\/3692065","volume":"2022","author":"Assadpour S.","year":"2022","unstructured":"Assadpour S.; Shiran M.R.; Asadi P.; Akhtari J.; Sahebkar A.; Harnessing intranasal delivery systems of sumatriptan for the treatment of migraine. BioMed Res Int  2022,2022(1),3692065","journal-title":"BioMed Res Int"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3390\/pharmaceutics13111828","volume":"13","author":"El Taweel M.M.","year":"2021","unstructured":"El Taweel M.M.; Aboul-Einien M.H.; Kassem M.A.; Elkasabgy N.A.; Intranasal zolmitriptan-loaded bilosomes with extended nasal mucociliary transit time for direct nose to brain delivery. Pharmaceutics  2021,13(11),1828","journal-title":"Pharmaceutics"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/1567201819666220401091632","volume":"20","author":"Tanna V.","year":"2023","unstructured":"Tanna V.; Sawarkar S.P.; Ravikumar P.; Exploring nose to brain nano delivery for effective management of migraine. Curr Drug Deliv  2023,20(2),144-157","journal-title":"Curr Drug Deliv"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.euroneuro.2023.03.008","volume":"71","author":"Kooij K.L.","year":"2023","unstructured":"Kooij K.L.; Luijendijk M.C.M.; Drost L.; Platenburg G.; van Elburg A.; Adan R.A.H.; Intranasal administration of olanzapine has beneficial outcome in a rat activity-based anorexia model. Eur Neuropsychopharmacol  2023,71,65-74","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"306","DOI":"10.4168\/aair.2019.11.3.306","volume":"11","author":"Jiao J.","year":"2019","unstructured":"Jiao J.; Zhang L.; Influence of intranasal drugs on human nasal mucociliary clearance and ciliary beat frequency. Allergy Asthma Immunol Res  2019,11(3),306-319","journal-title":"Allergy Asthma Immunol Res"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"103526","DOI":"10.1016\/j.jddst.2022.103526","volume":"74","author":"Kumar R.","year":"2022","unstructured":"Kumar R.; Dkhar D.S.; Kumari R.; Divya ; Mahapatra S.; Dubey V.K.; Chandra P.; Lipid based nanocarriers: Production techniques, concepts, and commercialization aspect. J Drug Deliv Sci Technol  2022,74,103526","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","volume":"3","author":"Mehta M.","year":"2023","unstructured":"Mehta M.; Bui T.A.; Yang X.; Aksoy Y.; Goldys E.M.; Deng W.; Lipid-based nanoparticles for drug\/gene delivery: An overview of the production techniques and difficulties encountered in their industrial development. ACS Mater Au  2023,3(6),600-619","journal-title":"ACS Mater Au"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"15764","DOI":"10.3390\/ijms242115764","volume":"24","author":"Ashfaq R.","year":"2023","unstructured":"Ashfaq R.; Rasul A.; Asghar S.; Kov\u00e1cs A.; Berk\u00f3 S.; Budai-Sz\u0171cs M.; Lipid nanoparticles: An effective tool to improve the bioavailability of nutraceuticals. Int J Mol Sci  2023,24(21),15764","journal-title":"Int J Mol Sci"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"105007","DOI":"10.1016\/j.jddst.2023.105007","volume":"89","author":"Al Jayoush A.R.","year":"2023","unstructured":"Al Jayoush A.R.; Hassan H.A.F.M.; Asiri H.; Jafar M.; Saeed R.; Harati R.; Haider M.; Niosomes for nose-to-brain delivery: A non-invasive versatile carrier system for drug delivery in neurodegenerative diseases. J Drug Deliv Sci Technol  2023,89,105007","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"09394","DOI":"10.1016\/j.heliyon.2022.e09394","volume":"8","author":"Nsairat H.","year":"2022","unstructured":"Nsairat H.; Khater D.; Sayed U.; Odeh F.; Al Bawab A.; Alshaer W.; Liposomes: Structure, composition, types, and clinical applications. Heliyon  2022,8(5),09394","journal-title":"Heliyon"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3390\/molecules27041372","volume":"27","author":"Liu P.","year":"2022","unstructured":"Liu P.; Chen G.; Zhang J.; A review of liposomes as a drug delivery system: Current status of approved products, regulatory environments, and future perspectives. Molecules  2022,27(4),1372","journal-title":"Molecules"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"122588","DOI":"10.1016\/j.ijpharm.2023.122588","volume":"632","author":"Elhabak M.","year":"2023","unstructured":"Elhabak M.; Salama A.A.A.; Salama A.H.; Nose-to-brain delivery of galantamine loaded nanospray dried polyacrylic acid\/taurodeoxycholate mixed matrix as a protective therapy in lipopolysaccharide-induced Alzheimer\u2019s in mice model. Int J Pharm  2023,632,122588","journal-title":"Int J Pharm"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/DDDT.S113171","volume":"10","author":"Al Asmari A.K.","year":"2016","unstructured":"Al Asmari A.K.; Ullah Z.; Tariq M.; Fatani A.; Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil. Drug Des Devel Ther  2016,10,205-215","journal-title":"Drug Des Devel Ther"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1208\/s12248-021-00648-z","volume":"23","author":"Juhairiyah F.","year":"2021","unstructured":"Juhairiyah F.; de Lange E.C.M.; Understanding drug delivery to the brain using liposome-based strategies: Studies that provide mechanistic insights are essential. AAPS J  2021,23(6),114","journal-title":"AAPS J"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"119604","DOI":"10.1016\/j.ijpharm.2020.119604","volume":"587","author":"Nolay F.","year":"2020","unstructured":"Nolay F.; Sevin E.; L\u00e9t\u00e9v\u00e9 M.; Bil A.; Gosselet F.; El Kirat K.; Djedaini-Pilard F.; Morandat S.; Fenart L.; Przybylski C.; Bonnet V.; First step to the improvement of the blood brain barrier passage of atazanavir encapsulated in sustainable bioorganic vesicles. Int J Pharm  2020,587,119604","journal-title":"Int J Pharm"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"102377","DOI":"10.1016\/j.jddst.2021.102377","volume":"63","author":"Prajapati J.B.","year":"2021","unstructured":"Prajapati J.B.; Patel G.C.; Nose to brain delivery of Rotigotine loaded solid lipid nanoparticles: Quality by design based optimization and characterization. J Drug Deliv Sci Technol  2021,63,102377","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"716","DOI":"10.5530\/ijper.56.3.120","volume":"56","author":"Attri K.","year":"2022","unstructured":"Attri K.; Singh M.; Bhalla V.; Xylometazoline loaded chitosan nanoparticles: Fabrication, optimization and evaluation for nasal congestion. Indian J Pharma Educat Res  2022,56(3),716-722","journal-title":"Indian J Pharma Educat Res"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s42256-024-00859-x","volume":"6","author":"Yang L.","year":"2024","unstructured":"Yang L.; Jiang J.; Ji F.; Li Y.; Yung K.L.; Ferreira A.; Zhang L.; Machine learning for micro- and nanorobots. Nat Mach Intell  2024,6(6),605-618","journal-title":"Nat Mach Intell"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1080\/10717544.2022.2058651","volume":"29","author":"Agrawal Y.","year":"2022","unstructured":"Agrawal Y.; Patil K.; Mahajan H.; Potdar M.; Joshi P.; Nakhate K.; Sharma C.; Goyal S.N.; Ojha S.; In vitro and in vivo characterization of Entacapone-loaded nanostructured lipid carriers developed by quality-by-design approach. Drug Deliv  2022,29(1),1112-1121","journal-title":"Drug Deliv"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ejpb.2023.08.018","volume":"191","author":"Mittal S.","year":"2023","unstructured":"Mittal S.; Shah S.; Yadav H.N.; Ali J.; Gupta M.M.; Baboota S.; Quality by design engineered, enhanced anticancer activity of temozolomide and resveratrol coloaded NLC and brain targeting via lactoferrin conjugation in treatment of glioblastoma. Eur J Pharm Biopharm  2023,191,175-188","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2174\/1567201814666171013150534","volume":"15","author":"Patel A.A.","year":"2018","unstructured":"Patel A.A.; Patel R.J.; Patel S.R.; Nanomedicine for intranasal delivery to improve brain uptake. Curr Drug Deliv  2018,15(4),461-469","journal-title":"Curr Drug Deliv"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/pharmaceutics14030543","volume":"14","author":"Lombardo D.","year":"2022","unstructured":"Lombardo D.; Kiselev M.A.; Methods of liposomes preparation: Formation and control factors of versatile nanocarriers for biomedical and nanomedicine application. Pharmaceutics  2022,14(3),543","journal-title":"Pharmaceutics"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"09030","DOI":"10.1016\/j.heliyon.2022.e09030","volume":"8","author":"Yuwanda A.","year":"2022","unstructured":"Yuwanda A.; Surini S.; Harahap Y.; Jufri M.; Study of valproic acid liposomes for delivery into the brain through an intranasal route. Heliyon  2022,8(3),09030","journal-title":"Heliyon"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejps.2017.09.039","volume":"111","author":"Kaldybekov D.B.","year":"2018","unstructured":"Kaldybekov D.B.; Tonglairoum P.; Opanasopit P.; Khutoryanskiy V.V.; Mucoadhesive maleimide-functionalised liposomes for drug delivery to urinary bladder. Eur J Pharm Sci  2018,111,83-90","journal-title":"Eur J Pharm Sci"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.3390\/pharmaceutics14091798","volume":"14","author":"N\u00e9meth Z.","year":"2022","unstructured":"N\u00e9meth Z.; Cs\u00f3ka I.; Semnani Jazani R.; Sipos B.; Haspel H.; Kozma G.; K\u00f3nya Z.; Dob\u00f3 D.G.; Quality by design-driven zeta potential optimisation study of liposomes with charge imparting membrane additives. Pharmaceutics  2022,14(9),1798","journal-title":"Pharmaceutics"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s40263-022-00930-4","volume":"36","author":"Lofts A.","year":"2022","unstructured":"Lofts A.; Abu-Hijleh F.; Rigg N.; Mishra R.K.; Hoare T.; Using the intranasal route to administer drugs to treat neurological and psychiatric illnesses: Rationale, successes, and future needs. CNS Drugs  2022,36(7),739-770","journal-title":"CNS Drugs"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cis.2012.08.002","volume":"183-184","author":"Mahale N.B.","year":"2012","unstructured":"Mahale N.B.; Thakkar P.D.; Mali R.G.; Walunj D.R.; Chaudhari S.R.; Niosomes: Novel sustained release nonionic stable vesicular systems \u2014 An overview. Adv Colloid Interface Sci  2012,183-184,46-54","journal-title":"Adv Colloid Interface Sci"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"9668","DOI":"10.3390\/ijms23179668","volume":"23","author":"Witika B.A.","year":"2022","unstructured":"Witika B.A.; Bassey K.E.; Demana P.H.; Siwe-Noundou X.; Poka M.S.; Current advances in specialised niosomal drug delivery: Manufacture, characterization and drug delivery applications. Int J Mol Sci  2022,23(17),9668","journal-title":"Int J Mol Sci"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"106052","DOI":"10.1016\/j.ejps.2021.106052","volume":"168","author":"Aparajay P.","year":"2022","unstructured":"Aparajay P.; Dev A.; Functionalized niosomes as a smart delivery device in cancer and fungal infection. Eur J Pharm Sci  2022,168,106052","journal-title":"Eur J Pharm Sci"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.2174\/0929867330666221115103513","volume":"30","author":"Zakharova L.","year":"2023","unstructured":"Zakharova L.; Gaynanova G.; Vasilieva E.; Vasileva L.; Pavlov R.; Kashapov R.; Petrov K.; Sinyashin O.; Recent nanoscale carriers for therapy of alzheimer\u2019s disease: Current strategies and perspectives. Curr Med Chem  2023,30(33),3743-3774","journal-title":"Curr Med Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.nano.2016.12.014","volume":"13","author":"Kulkarni J.A.","year":"2017","unstructured":"Kulkarni J.A.; Myhre J.L.; Chen S.; Tam Y.Y.C.; Danescu A.; Richman J.M.; Cullis P.R.; Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA. Nanomedicine  2017,13(4),1377-1387","journal-title":"Nanomedicine"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.bbrc.2020.10.054","volume":"534","author":"Asadikaram G.","year":"2021","unstructured":"Asadikaram G.; Poustforoosh A.; Pardakhty A.; Torkzadeh-Mahani M.; Nematollahi M.H.; Niosomal virosome derived by vesicular stomatitis virus glycoprotein as a new gene carrier. Biochem Biophys Res Commun  2021,534,980-987","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"105011","DOI":"10.1016\/j.jddst.2023.105011","volume":"89","author":"Rajizadeh M.A.","year":"2023","unstructured":"Rajizadeh M.A.; Motamedy S.; Mir Y.; Akhgarandouz F.; Nematollahi M.H.; Nezhadi A.; A comprehensive and updated review on the applications of vesicular drug delivery systems in treatment of brain disorders: A shelter against storms. J Drug Deliv Sci Technol  2023,89,105011","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2021.02.015","volume":"163","author":"Kulkarni P.","year":"2021","unstructured":"Kulkarni P.; Rawtani D.; Barot T.; Design, development and in-vitro\/in-vivo evaluation of intranasally delivered Rivastigmine and N-Acetyl Cysteine loaded bifunctional niosomes for applications in combinative treatment of Alzheimer\u2019s disease. Eur J Pharm Biopharm  2021,163,1-15","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ijbiomac.2022.06.031","volume":"213","author":"Ourani-Pourdashti S.","year":"2022","unstructured":"Ourani-Pourdashti S.; Mirzaei E.; Heidari R.; Ashrafi H.; Azadi A.; Preparation and evaluation of niosomal chitosan-based in situ gel formulation for direct nose-to-brain methotrexate delivery. Int J Biol Macromol  2022,213,1115-1126","journal-title":"Int J Biol Macromol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s12247-022-09636-y","volume":"18","author":"Gangopadhyay A.","year":"2023","unstructured":"Gangopadhyay A.; Dandagi P.M.; Sutar K.P.; Development and evaluation of thermoreversible ethosomal gel of donepezil hydrochloride for intranasal delivery. J Pharm Innov  2023,18(1),238-246","journal-title":"J Pharm Innov"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/NSA.S442951","volume":"17","author":"Hamzah M.","year":"2024","unstructured":"Hamzah M.; Kassab H.; Formulation and characterization of intranasal drug delivery of frovatriptan-loaded binary ethosomes gel for brain targeting. Nanotechnol Sci Appl  2024,17,1-19","journal-title":"Nanotechnol Sci Appl"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1208\/s12249-021-02020-y","volume":"22","author":"El-Shenawy A.A.","year":"2021","unstructured":"El-Shenawy A.A.; Mahmoud R.A.; Mahmoud E.A.; Mohamed M.S.; Intranasal in situ gel of apixaban-loaded nanoethosomes: Preparation, optimization, and in vivo evaluation. AAPS PharmSciTech  2021,22(4),147","journal-title":"AAPS PharmSciTech"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"101304","DOI":"10.1016\/j.jddst.2019.101304","volume":"54","author":"Eid H.M.","year":"2019","unstructured":"Eid H.M.; Elkomy M.H.; El Menshawe S.F.; Salem H.F.; Transfersomal nanovesicles for nose-to-brain delivery of ofloxacin for better management of bacterial meningitis: Formulation, optimization by Box-Behnken design, characterization and in vivo pharmacokinetic study. J Drug Deliv Sci Technol  2019,54,101304","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"43290","DOI":"10.1021\/acsomega.2c06215","volume":"7","author":"Mishra G.","year":"2022","unstructured":"Mishra G.; Awasthi R.; Singh A.K.; Singh S.; Mishra S.K.; Singh S.K.; Nandi M.K.; RETRACTED: Intranasally co-administered berberine and curcumin loaded in transfersomal vesicles improved inhibition of amyloid formation and bace-1. ACS Omega  2022,7(47),43290-43305","journal-title":"ACS Omega"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1208\/s12249-019-1353-8","volume":"20","author":"Salem H.F.","year":"2019","unstructured":"Salem H.F.; Kharshoum R.M.; Abou-Taleb H.A.; Naguib D.M.; Nanosized Transferosome-Based Intranasal In Situ Gel for Brain Targeting of Resveratrol: Formulation, Optimization, In Vitro Evaluation, and In Vivo Pharmacokinetic Study. AAPS PharmSciTech  2019,20(5),181","journal-title":"AAPS PharmSciTech"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"113450","DOI":"10.1016\/j.biopha.2022.113450","volume":"153","author":"Nojoki F.","year":"2022","unstructured":"Nojoki F.; Ebrahimi-Hosseinzadeh B.; Hatamian-Zarmi A.; Khodagholi F.; Khezri K.; Design and development of chitosan-insulin-transfersomes (Transfersulin) as effective intranasal nanovesicles for the treatment of Alzheimer\u2019s disease: In vitro, in vivo, and ex vivo evaluations. Biomed Pharmacother  2022,153,113450","journal-title":"Biomed Pharmacother"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejpb.2019.12.014","volume":"148","author":"Akel H.","year":"2020","unstructured":"Akel H.; Ismail R.; Cs\u00f3ka I.; Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer\u2019s disease. Eur J Pharm Biopharm  2020,148,38-53","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=89","author":"Hern\u00e1ndez-Esquivel R-A.","year":"2022","unstructured":"Hern\u00e1ndez-Esquivel R-A.; Navarro-Tovar G.; Z\u00e1rate-Hern\u00e1ndez E.; Aguirre-Ba\u00f1uelos P.; Solid lipid nanoparticles (SLN). Nanocomposite materials for biomedical and energy storage applications  2022","journal-title":"Nanocomposite materials for biomedical and energy storage applications"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"102871","DOI":"10.1016\/j.cis.2023.102871","volume":"314","author":"Grav\u00e1n P.","year":"2023","unstructured":"Grav\u00e1n P.; Aguilera-Garrido A.; Marchal J.A.; Navarro-Marchal S.A.; Galisteo-Gonz\u00e1lez F.; Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment. Adv Colloid Interface Sci  2023,314,102871","journal-title":"Adv Colloid Interface Sci"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/pharmaceutics14010131","volume":"14","author":"Alajami H.N.","year":"2022","unstructured":"Alajami H.N.; Fouad E.A.; Ashour A.E.; Kumar A.; Yassin A.E.B.; Celecoxib-loaded solid lipid nanoparticles for colon delivery: Formulation optimization and in vitro assessment of anti-cancer activity. Pharmaceutics  2022,14(1),131","journal-title":"Pharmaceutics"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jsps.2023.05.011","volume":"31","author":"Almawash S.","year":"2023","unstructured":"Almawash S.; Solid lipid nanoparticles, an effective carrier for classical antifungal drugs. Saudi Pharm J  2023,31(7),1167-1180","journal-title":"Saudi Pharm J"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2174\/2211738507666190802140607","volume":"7","author":"Gambhire V.M.","year":"2019","unstructured":"Gambhire V.M.; Gambhire M.S.; Ranpise N.S.; Solid lipid nanoparticles of dronedarone hydrochloride for oral delivery: Optimization, in vivo pharmacokinetics and uptake studies. Pharm Nanotechnol  2019,7(5),375-388","journal-title":"Pharm Nanotechnol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2017018693","volume":"34","author":"Cunha S.","year":"2017","unstructured":"Cunha S.; Amaral M.H.; Lobo J.M.S.; Silva A.C.; Lipid nanoparticles for nasal\/intranasal drug delivery. Crit Rev Ther Drug Carrier Syst  2017,34(3),257-282","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.2147\/IJN.S87148","volume":"10","author":"Fonseca-Santos B.","year":"2015","unstructured":"Fonseca-Santos B.; Chorilli M.; Palmira Daflon Gremi\u00e3o M.; Nanotechnology-based drug delivery systems for the treatment of Alzheimer\u2019s disease. Int J Nanomedicine  2015,10,4981-5003","journal-title":"Int J Nanomedicine"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"86","DOI":"10.22159\/ijap.2020v12i2.36812","volume":"12","author":"Mostafa D.A.E.","year":"2020","unstructured":"Mostafa D.A.E.; Khalifa M.K.A.; Gad Sameh S.; Zolmitriptan brain targeting via intranasal route using solid lipid nanoparticles for migraine therapy: Formulation, characterization, in-vitro and in-vivo assessment. Int J Appl Pharm  2020,12(2),86-93","journal-title":"Int J Appl Pharm"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"111076","DOI":"10.1016\/j.colsurfb.2020.111076","volume":"193","author":"Abdel Hady M.","year":"2020","unstructured":"Abdel Hady M.; Sayed O.M.; Akl M.A.; Brain uptake and accumulation of new levofloxacin-doxycycline combination through the use of solid lipid nanoparticles: Formulation; Optimization and in-vivo evaluation. Colloids Surf B Biointerfaces  2020,193,111076","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"120881","DOI":"10.1016\/j.ijpharm.2021.120881","volume":"606","author":"Uppuluri C.T.","year":"2021","unstructured":"Uppuluri C.T.; Ravi P.R.; Dalvi A.V.; Design, optimization and pharmacokinetic evaluation of Piribedil loaded solid lipid nanoparticles dispersed in nasal in situ gelling system for effective management of Parkinson\u2019s disease. Int J Pharm  2021,606,120881","journal-title":"Int J Pharm"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"150","DOI":"10.34172\/apb.2020.021","volume":"10","author":"Chauhan I.","year":"2020","unstructured":"Chauhan I.; Yasir M.; Verma M.; Singh A.P.; Nanostructured lipid carriers: A groundbreaking approach for transdermal drug delivery. Adv Pharm Bull  2020,10(2),150-165","journal-title":"Adv Pharm Bull"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s40005-016-0228-1","volume":"46","author":"Jaiswal M.","year":"2016","unstructured":"Jaiswal M.; Kumar A.; Sharma S.; Nanoemulsions loaded Carbopol\u00ae 934 based gel for intranasal delivery of neuroprotective Centella asiatica extract: In\u2013vitro and ex\u2013vivo permeation study. J Pharm Investig  2016,46(1),79-89","journal-title":"J Pharm Investig"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/s0939-6411(00)00087-4","volume":"50","author":"M\u00fcller RH","year":"2000","unstructured":"M\u00fcller RH; M\u00e4der K; Gohla S; Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm  2000,50(1),161-177","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3390\/pharmaceutics14081668","volume":"14","author":"Alavi S.E.","year":"2022","unstructured":"Alavi S.E.; Bakht U.; Koohi Moftakhari Esfahani M.; Adelnia H.; Abdollahi S.H.; Ebrahimi Shahmabadi H.; Raza A.; A PEGylated nanostructured lipid carrier for enhanced oral delivery of antibiotics. Pharmaceutics  2022,14(8),1668","journal-title":"Pharmaceutics"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"6009309","DOI":"10.1155\/2022\/6009309","volume":"2022","author":"Sartaj A.","year":"2022","unstructured":"Sartaj A.; Annu ; Biswas L.; Verma A.K.; Sahoo P.K.; Baboota S.; Ali J.; Ribociclib nanostructured lipid carrier aimed for breast cancer: Formulation optimization, attenuating in vitro specification, and in vivo scrutinization. BioMed Res Int  2022,2022(1),6009309","journal-title":"BioMed Res Int"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.nano.2015.09.004","volume":"12","author":"Beloqui A.","year":"2016","unstructured":"Beloqui A.; Solin\u00eds M.\u00c1.; Rodr\u00edguez-Gasc\u00f3n A.; Almeida A.J.; Pr\u00e9at V.; Nanostructured lipid carriers: Promising drug delivery systems for future clinics. Nanomedicine  2016,12(1),143-161","journal-title":"Nanomedicine"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.foodres.2014.05.059","volume":"62","author":"Pandita D.","year":"2014","unstructured":"Pandita D.; Kumar S.; Poonia N.; Lather V.; Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol. Food Res Int  2014,62,1165-1174","journal-title":"Food Res Int"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1517\/17425247.2016.1151872","volume":"13","author":"Rao S.","year":"2016","unstructured":"Rao S.; Prestidge C.A.; Polymer-lipid hybrid systems: Merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery. Expert Opin Drug Deliv  2016,13(5),691-707","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.addr.2007.04.006","volume":"59","author":"Sch\u00e4ferkorting M.","year":"2007","unstructured":"Sch\u00e4ferkorting M.; Mehnert W.; Korting H.; Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev  2007,59(6),427-443","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3390\/pharmaceutics13040581","volume":"13","author":"Abourehab M.A.S.","year":"2021","unstructured":"Abourehab M.A.S.; Khames A.; Genedy S.; Mostafa S.; Khaleel M.A.; Omar M.M.; El Sisi A.M.; Sesame oil-based nanostructured lipid carriers of nicergoline, intranasal delivery system for brain targeting of synergistic cerebrovascular protection. Pharmaceutics  2021,13(4),581","journal-title":"Pharmaceutics"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"122232","DOI":"10.1016\/j.ijpharm.2022.122232","volume":"627","author":"Zafar A.","year":"2022","unstructured":"Zafar A.; Awad Alsaidan O.; Alruwaili N.K.; Sarim Imam S.; Yasir M.; Saad Alharbi K.; Singh L.; Muqtader Ahmed M.; Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation. Int J Pharm  2022,627,122232","journal-title":"Int J Pharm"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1208\/s12249-024-02736-7","volume":"25","author":"Sonawane D.","year":"2024","unstructured":"Sonawane D.; Pokharkar V.; Quercetin-loaded nanostructured lipid carrier in situ gel for brain targeting through intranasal route: Formulation, in vivo pharmacokinetic and pharmacodynamic studies. AAPS PharmSciTech  2024,25(2),30","journal-title":"AAPS PharmSciTech"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"012006","DOI":"10.1088\/2632-959X\/abeb4b","volume":"2","author":"Persano F.","year":"2021","unstructured":"Persano F.; Gigli G.; Leporatti S.; Lipid-polymer hybrid nanoparticles in cancer therapy: Current overview and future directions. Nano Express  2021,2(1),012006","journal-title":"Nano Express"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","volume":"15","author":"Tenchov R.","year":"2021","unstructured":"Tenchov R.; Bird R.; Curtze A.E.; Zhou Q.; Lipid nanoparticles\u2500from liposomes to mrna vaccine delivery, a landscape of research diversity and advancement. ACS Nano  2021,15(11),16982-17015","journal-title":"ACS Nano"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2174\/2405461508666230804103023","volume":"9","author":"Jena D.","year":"2024","unstructured":"Jena D.; Srivastava N.; Yasir M.; Dan D.; Intranasal delivery of lipid nanoparticles: A ground-breaking approach for brain targeting. Curr Nanomater  2024,9(3),209-223","journal-title":"Curr Nanomater"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.biomaterials.2017.02.019","volume":"125","author":"Persano S.","year":"2017","unstructured":"Persano S.; Guevara M.L.; Li Z.; Mai J.; Ferrari M.; Pompa P.P.; Shen H.; Lipopolyplex potentiates anti-tumor immunity of mRNA-based vaccination. Biomaterials  2017,125,81-89","journal-title":"Biomaterials"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2174\/1567201815666181011121750","volume":"16","author":"Qureshi M.","year":"2018","unstructured":"Qureshi M.; Aqil M.; Imam S.S.; Ahad A.; Sultana Y.; Formulation and evaluation of neuroactive drug loaded chitosan nanoparticle for nose to brain delivery: In-vitro characterization and in-vivo behavior study. Curr Drug Deliv  2018,16(2),123-135","journal-title":"Curr Drug Deliv"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/j.xphs.2020.04.007","volume":"109","author":"Salem L.H.","year":"2020","unstructured":"Salem L.H.; El-Feky G.S.; Fahmy R.H.; El Gazayerly O.N.; Abdelbary A.; Coated lipidic nanoparticles as a new strategy for enhancing nose-to-brain delivery of a hydrophilic drug molecule. J Pharm Sci  2020,109(7),2237-2251","journal-title":"J Pharm Sci"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2174\/156720112803529792","volume":"9","author":"Bahadur S.","year":"2012","unstructured":"Bahadur S.; Pathak K.; Buffered nanoemulsion for nose to brain delivery of ziprasidone hydrochloride: Preformulation and pharmacodynamic evaluation. Curr Drug Deliv  2012,9(6),596-607","journal-title":"Curr Drug Deliv"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1208\/s12249-016-0552-9","volume":"18","author":"Boche M.","year":"2017","unstructured":"Boche M.; Pokharkar V.; Quetiapine nanoemulsion for intranasal drug delivery: Evaluation of brain-targeting efficiency. AAPS PharmSciTech  2017,18(3),686-696","journal-title":"AAPS PharmSciTech"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ijpharm.2008.03.029","volume":"358","author":"Kumar M.","year":"2008","unstructured":"Kumar M.; Misra A.; Babbar A.K.; Mishra A.K.; Mishra P.; Pathak K.; Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int J Pharm  2008,358(1-2),285-291","journal-title":"Int J Pharm"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3109\/10717544.2013.838014","volume":"21","author":"Mahajan H.S.","year":"2014","unstructured":"Mahajan H.S.; Mahajan M.S.; Nerkar P.P.; Agrawal A.; Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting. Drug Deliv  2014,21(2),148-154","journal-title":"Drug Deliv"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1007\/s13346-020-00754-z","volume":"10","author":"Kaur A.","year":"2020","unstructured":"Kaur A.; Nigam K.; Bhatnagar I.; Sukhpal H.; Awasthy S.; Shankar S.; Tyagi A.; Dang S.; Treatment of Alzheimer\u2019s diseases using donepezil nanoemulsion: An intranasal approach. Drug Deliv Transl Res  2020,10(6),1862-1875","journal-title":"Drug Deliv Transl Res"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ejps.2012.12.007","volume":"48","author":"Md S.","year":"2013","unstructured":"Md S.; Khan R.A.; Mustafa G.; Chuttani K.; Baboota S.; Sahni J.K.; Ali J.; Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: Pharmacodynamic, Pharmacokinetic and Scintigraphy study in mice model. Eur J Pharm Sci  2013,48(3),393-405","journal-title":"Eur J Pharm Sci"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ijbiomac.2014.03.022","volume":"67","author":"Bhavna","year":"2014","unstructured":"Bhavna ; Md S.; Ali M.; Ali R.; Bhatnagar A.; Baboota S.; Ali J.; Donepezil nanosuspension intended for nose to brain targeting: In vitro and in vivo safety evaluation. Int J Biol Macromol  2014,67,418-425","journal-title":"Int J Biol Macromol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3109\/10717544.2014.907372","volume":"23","author":"Mittal D.","year":"2016","unstructured":"Mittal D.; Md S.; Hasan Q.; Fazil M.; Ali A.; Baboota S.; Ali J.; Brain targeted nanoparticulate drug delivery system of rasagiline via intranasal route. Drug Deliv  2016,23(1),130-139","journal-title":"Drug Deliv"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/pharmaceutics11010026","volume":"11","author":"Tzeyung A.","year":"2019","unstructured":"Tzeyung A.; Md S.; Bhattamisra S.; Madheswaran T.; Alhakamy N.; Aldawsari H.; Radhakrishnan A.; RETRACTED: Fabrication, optimization, and evaluation of rotigotine-loaded chitosan nanoparticles for nose-to-brain delivery. Pharmaceutics  2019,11(1),26","journal-title":"Pharmaceutics"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2174\/1570163815666180418144019","volume":"16","author":"Rukmangathen R.","year":"2019","unstructured":"Rukmangathen R.; Yallamalli I.M.; Yalavarthi P.R.; Biopharmaceutical potential of selegiline loaded chitosan nanoparticles in the management of parkinson\u2019s disease. Curr Drug Discov Technol  2019,16(4),417-425","journal-title":"Curr Drug Discov Technol"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/brainsci9100275","volume":"9","author":"Md S.","year":"2019","unstructured":"Md S.; Alhakamy N.A.; Aldawsari H.M.; Asfour H.Z.; Neuroprotective and antioxidant effect of naringenin-loaded nanoparticles for nose-to-brain delivery. Brain Sci  2019,9(10),275","journal-title":"Brain Sci"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ijbiomac.2022.08.210","volume":"221","author":"Ahmad S.","year":"2022","unstructured":"Ahmad S.; Khan I.; Pandit J.; Emad N.A.; Bano S.; Dar K.I.; Rizvi M.M.A.; Ansari M.D.; Aqil M.; Sultana Y.; Brain targeted delivery of carmustine using chitosan coated nanoparticles via nasal route for glioblastoma treatment. Int J Biol Macromol  2022,221,435-445","journal-title":"Int J Biol Macromol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.ijbiomac.2020.11.047","volume":"167","author":"Gadhave D.","year":"2021","unstructured":"Gadhave D.; Rasal N.; Sonawane R.; Sekar M.; Kokare C.; Nose-to-brain delivery of teriflunomide-loaded lipid-based carbopol-gellan gum nanogel for glioma: Pharmacological and in vitro cytotoxicity studies. Int J Biol Macromol  2021,167,906-920","journal-title":"Int J Biol Macromol"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"119990","DOI":"10.1016\/j.lfs.2021.119990","volume":"285","author":"Raju M.","year":"2021","unstructured":"Raju M.; Kunde S.S.; Auti S.T.; Kulkarni Y.A.; Wairkar S.; Berberine loaded nanostructured lipid carrier for Alzheimer\u2019s disease: Design, statistical optimization and enhanced in vivo performance. Life Sci  2021,285,119990","journal-title":"Life Sci"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"102939","DOI":"10.1016\/j.jddst.2021.102939","volume":"67","author":"Noorulla K.M.","year":"2022","unstructured":"Noorulla K.M.; Yasir M.; Muzaffar F.; S R.; Ghoneim M.M.; Almurshedi A.S.; Tura A.J.; Alshehri S.; Gebissa T.; Mekit S.; Ahmed M.M.; Zafar A.; Intranasal delivery of chitosan decorated nanostructured lipid carriers of Buspirone for brain targeting: Formulation development, optimization and In-Vivo preclinical evaluation. J Drug Deliv Sci Technol  2022,67,102939","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"212827","DOI":"10.1016\/j.bioadv.2022.212827","volume":"137","author":"Khonsari F.","year":"2022","unstructured":"Khonsari F.; Heydari M.; Sharifzadeh M.; Valizadeh H.; Dinarvand R.; Atyabi F.; Transferrin decorated-nanostructured lipid carriers (NLCs) are a promising delivery system for rapamycin in Alzheimer\u2019s disease: An in vivo study. Biomater Adv  2022,137,212827","journal-title":"Biomater Adv"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"105160","DOI":"10.1016\/j.jddst.2023.105160","volume":"90","author":"Shah S.","year":"2023","unstructured":"Shah S.; Patel A.A.; Pandya V.; Trivedi N.; Patel S.G.; Prajapati B.G.; Singh S.; Patel R.J.; Breaking barriers: Intranasal delivery of brexpiprazole-nanostructured lipid carriers targets the brain for effective schizophrenia treatment. J Drug Deliv Sci Technol  2023,90,105160","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"123345","DOI":"10.1016\/j.ijpharm.2023.123345","volume":"644","author":"Pina Costa C.","year":"2023","unstructured":"Pina Costa C.; Ni\u017ei\u0107 Nodilo L.; Silva R.; Martins E.; Zadravec D.; Kalogjera L.; Nuno Moreira J.; Manuel Sousa Lobo J.; Hafner A.; Catarina Silva A.; In situ hydrogel containing diazepam-loaded nanostructured lipid carriers (DZP-NLC) for nose-to-brain delivery: Development, characterization and deposition studies in a 3D-printed human nasal cavity model. Int J Pharm  2023,644,123345","journal-title":"Int J Pharm"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"100332","DOI":"10.1016\/j.carpta.2023.100332","volume":"6","author":"Nerli G.","year":"2023","unstructured":"Nerli G.; Robla S.; Bartalesi M.; Luceri C.; D\u2019Ambrosio M.; Csaba N.; Maestrelli F.; Chitosan coated niosomes for nose-to-brain delivery of clonazepam: Formulation, stability and permeability studies. Carbohydr Polym Technol Appl  2023,6,100332","journal-title":"Carbohydr Polym Technol Appl"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"100206","DOI":"10.1016\/j.ijpx.2023.100206","volume":"6","author":"Tulbah A.S.","year":"2023","unstructured":"Tulbah A.S.; Elkomy M.H.; Zaki R.M.; Eid H.M.; Eissa E.M.; Ali A.A.; Yassin H.A.; Aldosari B.N.; Naguib I.A.; Hassan A.H.; Novel nasal niosomes loaded with lacosamide and coated with chitosan: A possible pathway to target the brain to control partial-onset seizures. Int J Pharm X  2023,6,100206","journal-title":"Int J Pharm X"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"113723","DOI":"10.1016\/j.fct.2023.113723","volume":"175","author":"Long Y.","year":"2023","unstructured":"Long Y.; Yu S.; Li D.; Shi A.; Ma Y.; Deng J.; Li X.; Wen J.; Wu Y.; Hu Y.; He X.; Li N.; Han L.; Du J.; Preparation, characterization and safety evaluation of Ligusticum chuanxiong essential oils liposomes for treatment of cerebral ischemia-reperfusion injury. Food Chem Toxicol  2023,175,113723","journal-title":"Food Chem Toxicol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"105035","DOI":"10.1016\/j.chemphyslip.2020.105035","volume":"235","author":"Ashhar M.U.","year":"2021","unstructured":"Ashhar M.U.; Kumar S.; Ali J.; Baboota S.; CCRD based development of bromocriptine and glutathione nanoemulsion tailored ultrasonically for the combined anti-parkinson effect. Chem Phys Lipids  2021,235,105035","journal-title":"Chem Phys Lipids"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"121720","DOI":"10.1016\/j.ijpharm.2022.121720","volume":"620","author":"Cunha S.","year":"2022","unstructured":"Cunha S.; Swedrowska M.; Bellahnid Y.; Xu Z.; Sousa Lobo J.M.; Forbes B.; Silva A.C.; Thermosensitive in situ hydrogels of rivastigmine-loaded lipid-based nanosystems for nose-to-brain delivery: Characterisation, biocompatibility, and drug deposition studies. Int J Pharm  2022,620,121720","journal-title":"Int J Pharm"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3390\/antiox11020281","volume":"11","author":"Balakrishnan R.","year":"2022","unstructured":"Balakrishnan R.; Cho D.Y.; Kim I.S.; Seol S.H.; Choi D.K.; Molecular mechanisms and therapeutic potential of \u03b1- and \u03b2-asarone in the treatment of neurological disorders. Antioxidants  2022,11(2),281","journal-title":"Antioxidants"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"101692","DOI":"10.1016\/j.jsps.2023.06.025","volume":"31","author":"Alaayedi M.H.","year":"2023","unstructured":"Alaayedi M.H.; Maraie N.K.; Lomustine\u2019s nanoemulsion as nose-to-brain drug delivery system for CNS tumor treatment. Saudi Pharm J  2023,31(8),101692","journal-title":"Saudi Pharm J"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"100837","DOI":"10.1016\/j.mtbio.2023.100837","volume":"23","author":"Moammeri A.","year":"2023","unstructured":"Moammeri A.; Chegeni M.M.; Sahrayi H.; Ghafelehbashi R.; Memarzadeh F.; Mansouri A.; Akbarzadeh I.; Abtahi M.S.; Hejabi F.; Ren Q.; Current advances in niosomes applications for drug delivery and cancer treatment. Mater Today Bio  2023,23,100837","journal-title":"Mater Today Bio"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/cosmetics11060191","volume":"11","author":"Musielak E.","year":"2024","unstructured":"Musielak E.; Krajka-Ku\u017aniak V.; Liposomes and ethosomes: Comparative potential in enhancing skin permeability for therapeutic and cosmetic applications. Cosmetics  2024,11(6),191","journal-title":"Cosmetics"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3390\/pharmaceutics12090855","volume":"12","author":"Opatha S.A.T.","year":"2020","unstructured":"Opatha S.A.T.; Titapiwatanakun V.; Chutoprapat R.; Transfersomes: A promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics  2020,12(9),855","journal-title":"Pharmaceutics"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3390\/app13031726","volume":"13","author":"Tang C.H.","year":"2023","unstructured":"Tang C.H.; Chen H.L.; Dong J.R.; Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) as food-grade nanovehicles for hydrophobic nutraceuticals or bioactives. Appl Sci  2023,13(3),1726","journal-title":"Appl Sci"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/pharmaceutics16111376","volume":"16","author":"Rehman M.","year":"2024","unstructured":"Rehman M.; Tahir N.; Sohail M.F.; Qadri M.U.; Duarte S.O.D.; Brand\u00e3o P.; Esteves T.; Javed I.; Fonte P.; Lipid-based nanoformulations for drug delivery: An ongoing perspective. Pharmaceutics  2024,16(11),1376","journal-title":"Pharmaceutics"},{"key":"ref=147","doi-asserted-by":"publisher","DOI":"10.34172\/apb.2022.078","author":"Tekade A.R.","year":"2021","unstructured":"Tekade A.R.; Mittha P.S.; Pisal C.S.; Nanostructured lipid carriers for nose to brain delivery targeting cns: Diversified role of liquid lipids for synergistic action. Adv Pharm Bull  2021","journal-title":"Adv Pharm Bull"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejps.2018.01.032","volume":"117","author":"Inoue D.","year":"2018","unstructured":"Inoue D.; Tanaka A.; Kimura S.; Kiriyama A.; Katsumi H.; Yamamoto A.; Ogawara K.; Kimura T.; Higaki K.; Yutani R.; Sakane T.; Furubayashi T.; The relationship between in vivo nasal drug clearance and in vitro nasal mucociliary clearance: Application to the prediction of nasal drug absorption. Eur J Pharm Sci  2018,117,21-26","journal-title":"Eur J Pharm Sci"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.3390\/pharmaceutics16121521","volume":"16","author":"Catenacci L.","year":"2024","unstructured":"Catenacci L.; Rossi R.; Sechi F.; Buonocore D.; Sorrenti M.; Perteghella S.; Peviani M.; Bonferoni M.C.; Effect of lipid nanoparticle physico-chemical properties and composition on their interaction with the immune system. Pharmaceutics  2024,16(12),1521","journal-title":"Pharmaceutics"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"100551","DOI":"10.1016\/j.carpta.2024.100551","volume":"8","author":"Yadav H.","year":"2024","unstructured":"Yadav H.; Malviya R.; Kaushik N.; Chitosan in biomedicine: A comprehensive review of recent developments. Carbohydr Polym Technol Appl  2024,8,100551","journal-title":"Carbohydr Polym Technol Appl"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1016\/j.biomaterials.2013.02.003","volume":"34","author":"Liu Z.","year":"2013","unstructured":"Liu Z.; Jiang M.; Kang T.; Miao D.; Gu G.; Song Q.; Yao L.; Hu Q.; Tu Y.; Pang Z.; Chen H.; Jiang X.; Gao X.; Chen J.; Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration. Biomaterials  2013,34(15),3870-3881","journal-title":"Biomaterials"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ipha.2024.09.005","volume":"3","author":"Mall J.","year":"2025","unstructured":"Mall J.; Naseem N.; Haider Md.; Nanostructured lipid carriers as a drug delivery system: A comprehensive review with therapeutic applications. Intell Pharm  2025,3(4),243-255","journal-title":"Intell Pharm"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"48","DOI":"10.15587\/2706-5448.2024.299271","volume":"1","author":"Malyshev V.","year":"2024","unstructured":"Malyshev V.; Gab A.; Kovalenko V.; Pryshedko O.; Shakhnin D.; Estimation of global nanomedicine market: Status, segment analysis, dynamics, competition and prospects. Technol Audit Prod Res  2024,1(4(75)),48-59","journal-title":"Technol Audit Prod Res"},{"key":"ref=154","year":"2025","unstructured":"Intranasal insulin in parkinson's disease (INI-PD); NCT04251585.  Available from:  https:\/ \/classic.clinicaltrials.gov\/ct2\/show\/study\/NCT042515852025"},{"key":"ref=155","year":"2024","unstructured":"COMMETS- Combination MCI Metabolic syndrome; NCT06072963.  Available from:  https:\/\/Classic.Clinicaltrials.Gov\/Ct2\/Show\/NCT060729632024"},{"key":"ref=156","year":"2024","unstructured":"Pediatric dose optimization for seizures in emergency medical services (PediDOSE); NCT05121324.  Available from:  https:\/\/Classic.Clinicaltrials.Gov\/Ct2\/Show\/NCT051213242024"},{"key":"ref=157","year":"2024","unstructured":"Improving status epilepticus treatment times (QuITT-SE); NCT06194747.  Available from:  https:\/\/Classic.Clinicaltrials.Gov\/Ct2\/Show\/NCT061947472024"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"00581","DOI":"10.1016\/j.neurot.2025.e00581","volume":"22","author":"Newsome S.D.","year":"2025","unstructured":"Newsome S.D.; Fitzgerald K.C.; Hughes A.; Beier M.; Koshorek J.; Wang Y.; Maldonado D.P.; Shoemaker T.; Malik T.; Bayu T.; Ravenna P.E.; Avornu A.; Sotirchos E.S.; Romba M.; Muschelli J.; Brown T.T.; Calabresi P.A.; Mowry E.M.; Intranasal insulin for improving cognitive function in multiple sclerosis. Neurotherapeutics  2025,22(4),00581","journal-title":"Neurotherapeutics"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2174\/18755453MTEyjMzIn3","volume":"22","author":"Muheem A.","year":"2021","unstructured":"Muheem A.; Jahangir M.A.; Jaiswal C.P.; Jafar M.; Ahmad M.Z.; Ahmad J.; Warsi M.H.; Recent patents, regulatory issues, and toxicity of nanoparticles in neuronal disorders. Curr Drug Metab  2021,22(4),263-279","journal-title":"Curr Drug Metab"},{"key":"ref=160","author":"Srinivas M.","year":"2019","unstructured":"Srinivas M.; Nanostructured lipid carriers containing a typical antipsychotic drug for oral administration.  2019"},{"key":"ref=161","author":"Shailendra B.V.","year":"2017","unstructured":"Shailendra B.V.; Novel nanocarrier composition for brain targeting.  2017"},{"key":"ref=162","author":"Woo K.S.","year":"2019","unstructured":"Woo K.S.; Composition for increasing expression Of PGC-1alpha.  2019"},{"key":"ref=163","author":"Bhattacharya S.","year":"2019","unstructured":"Bhattacharya S.; Preparation and evaluation of solid lipid nano particles for cancer treatment.  2019"},{"key":"ref=164","author":"Kaili H.","year":"2017","unstructured":"Kaili H.; Brain\u2013targeting nanometer medication system modified by brain guiding drug and preparation method of brain-targeting nanometer medication system. CN Patent 2017106340544  2017","journal-title":"CN Patent 2017106340544"},{"key":"ref=165","author":"Alexander W.","year":"2019","unstructured":"Alexander W.; Methods J.R.; Methods and compositions for parenteral administration of cannabidiol in the treatment of convulsive disorders.  2019"},{"key":"ref=166","author":"Zhou J.","year":"2018","unstructured":"Zhou J.; Compositions for enhancing delivery of agents across the blood brain barrier and methods of use thereof.  2018"},{"key":"ref=167","author":"Shengrong G.","year":"2018","unstructured":"Shengrong G.; Poly curcumin based amphiphilic block copolymer and application thereof.  2018"},{"key":"ref=168","author":"Sung S.H.","year":"2018","unstructured":"Sung S.H.; A pharmaceutical composition comprising liposome containing phycocyanin or phycoerythrin as an active ingredient for brain disease.  2018"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115680266379726251115040906","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/252225\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115680266379726251115040906","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T04:15:18Z","timestamp":1785989718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/252225\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":168,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115680266379726251115040906","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-02-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}